Association between health systems performance and treatment outcomes in patients co-infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: implications for TB programmes. by Loveday, Marian Patricia. et al.
Association between Health Systems Performance and
Treatment Outcomes in Patients Co-Infected with MDR-
TB and HIV in KwaZulu-Natal, South Africa: Implications
for TB Programmes
Marian Loveday1*, Nesri Padayatchi2, Kristina Wallengren3, Jacquelin Roberts4, James C. M. Brust5,
Jacqueline Ngozo6, Iqbal Master7, Anna Voce8
1Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa, 2Centre for the AIDS Programme of Research in South Africa
(CAPRISA), University of KwaZulu-Natal, Durban, South Africa, 3 Tuberculosis & HIV Investigative Network of KwaZulu-Natal (THINK), Durban, South Africa, 4 Retired from
Centres for Disease Control and Prevention, Atlanta, Georgia, United States of America, 5Department of Medicine, Montefiore Medical Center & Albert Einstein College of
Medicine, Bronx, New York, United States of America, 6 KwaZulu-Natal Department of Health, Pietermaritzburg, South Africa, 7 King Dinuzulu Hospital Complex, KwaZulu-
Natal Department of Health, Durban, South Africa, 8Discipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa
Abstract
Objective: To improve the treatment of MDR-TB and HIV co-infected patients, we investigated the relationship between
health system performance and patient treatment outcomes at 4 decentralised MDR-TB sites.
Methods: In this mixed methods case study which included prospective comparative data, we measured health system
performance using a framework of domains comprising key health service components. Using Pearson Product Moment
Correlation coefficients we quantified the direction and magnitude of the association between health system performance
and MDR-TB treatment outcomes. Qualitative data from participant observation and interviews analysed using systematic
text condensation (STC) complemented our quantitative findings.
Findings: We found significant differences in treatment outcomes across the sites with successful outcomes varying from
72% at Site 1 to 52% at Site 4 (p,0.01). Health systems performance scores also varied considerably across the sites. Our
findings suggest there is a correlation between treatment outcomes and overall health system performance which is
significant (r = 0.99, p,0.01), with Site 1 having the highest number of successful treatment outcomes and the highest
health system performance. Although the ‘integration’ domain, which measured integration of MDR-TB services into
existing services appeared to have the strongest association with successful treatment outcomes (r = 0.99, p,0.01),
qualitative data indicated that the ‘context’ domain influenced the other domains.
Conclusion: We suggest that there is an association between treatment outcomes and health system performance. The
chance of treatment success is greater if decentralised MDR-TB services are integrated into existing services. To optimise
successful treatment outcomes, regular monitoring and support are needed at a district, facility and individual level to
ensure the local context is supportive of new programmes and implementation is according to guidelines.
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Introduction
In KwaZulu-Natal many patients have multidrug-resistant
tuberculosis (MDR-TB), defined as TB resistant to isoniazid and
rifampicin. [1] Fuelled by concomitant hyper-endemic TB and
HIV, KwaZulu-Natal has one of the largest drug-resistant TB
epidemics in the world. [1,2] Management of MDR-TB is
complex, and different interlinked health service components
influence each other affecting MDR-TB treatment outcomes. To
provide treatment for patients closer to their homes, a decen-
tralised model of treatment was initiated at four sites in 2009. To
guide implementation of the MDR-TB programme in the four
sites, provincial treatment guidelines were developed and distrib-
uted.
Successful implementation of any MDR-TB programme is
dependent on different health system components functioning
together to support effective service delivery, but there is limited
evidence on how programmes interact with health systems and
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which factors enable or hinder this interaction. [3–5] Further-
more, although much has been written about the patient and
disease characteristics that impact on MDR-TB treatment
outcomes (TOs), there is little evidence of the impact of health
system performance on TOs. [6] Negative health care worker
attitudes, drug stock-outs, large cohort size and limited resources
with which to trace defaulters are some of the factors which have
been described as contributing to poor TOs [7–10].
To evaluate implementation of the decentralised MDR-TB
programme we undertook a study comparing the effectiveness of
decentralised care for MDR-TB patients with care in a centralised
setting. [11,12] During the comparison we noted that the MDR-
TB programme was implemented differently at each decentralised
site. Furthermore, treatment outcomes varied considerably
between the sites, with some sites performing better than the
centralised hospital and others worse. To better understand the
diverse implementation and the subsequent varying treatment
outcomes, we performed an analysis of health systems factors. We
hypothesized, that treatment outcome was associated with local
health system factors and that by investigating the association, we
could identify those factors critical to successful treatment
outcomes.
To determine that association, ‘‘health system performance’’
(HSP) was defined as one variable. For each site, HSP was the
result of a composite assessment of four performance domains:
context, integration, mechanism and output. [13,14] Treatment
outcome (TO) at each site, our second variable, was based on the
site’s overall treatment outcomes.
In this exploratory prospective mixed methods health systems
comparative case study of the four sites, we addressed the
following research questions. (1) Is there an association between
treatment outcome (TO) and health system performance (HSP)?




The study protocol was approved by the University of
KwaZulu-Natal Biomedical Research Ethics Committee (Ref:
BF052/09), and by the KwaZulu-Natal Department of Health.
Only secondary data, the data routinely collected by health
workers for clinical care was used in this study. To protect patient
confidentiality and anonymity the data bases were de-identified
and access strictly limited. Informed consent was waived by the
ethics committee, since all patient data used were previously
collected during the course of routine medical care and did not
pose any additional risks to the patients.
Study Design
This mixed methods case study of four decentralized MDR-TB
sites between 1 July 2008 and 30 June 2012 was a prospective
health systems study.
Study Population
The Provincial TB directorate identified four sites, the cases for
our case study, for implementation of the decentralised MDR-TB
programme. These sites were purposively selected in areas where
large numbers of patients with MDR-TB were being diagnosed.
Although distributed widely across the province the infrastructure
and socio-economic status of the populations in these districts was
similar. These sites together with their health care workers and
managers were included in the study, as were district-level
managers involved in MDR-TB management from the districts
where the sites were based.
All patients from the four decentralised sites with a culture
confirmed diagnosis of MDR-TB, age >18 years, and who
commenced treatment between I July 2008 and 30 June 2010,
were included in the study. No data was collected after October 1,
2012. Inclusion criteria for the comparison study required that
patients reside within the catchment area of the site. Patients
receiving care at more than one site were excluded, as were
patients who had MDR-TB with additional resistance to amikacin,
kanamycin, capreomycin or any fluoroquinolone.
Data Collection
We reviewed medical records to collect patient-related demo-
graphic, clinical, pharmaceutical and laboratory data. All data,
was collected prospectively, prior to knowledge of patient
treatment outcomes. Health system data was collected from
different components of the health system - laboratory, pharma-
ceutical and transport services and human resources - using
existing records and databases, structured questionnaires, obser-
vation and interviews. As differences between the sites and
complexities emerged, an iterative approach enabled us to identify
new health system data required and develop appropriate data
collection methodologies.
Quantitative data was complemented by qualitative data
obtained through participant observation and discussions with
staff. Over the four year study period each site was visited monthly
for a day (ML). During each visit data from each health system
component was collected (see Table S1), the functioning of the
MDR-TB unit observed and informal discussions held with the
nurse-in-charge of the MDR-TB unit, the clinician responsible for
MDR-TB and the hospital pharmacist. Through a process of on-
going reflection, feedback and discussion with facility and district
level staff problems were investigated to determine their origin and
cause and possible solutions identified. Field notes detailing the
visit and documenting observations and discussions with staff were
written up after returning from the site. Notes were also made of
concerns, opinions and issues which needed follow up.
Variable Definitions
In defining the HSP variable we adapted a conceptual
framework, which had been validated both internationally and
in our setting, [13,14] and identified key domains of health system
performance – context, integration, mechanism (comprised of
support services and human resources) and output (Table 1). To
measure HSP we identified health system factors which would
affect system performance. Concomitant indicators with which to
measure the impact of these factors on each domain were then
identified and defined (Table 1).
To measure indicators, data collected at each site was scored by
an investigator (ML) and the nurse-in-charge of the MDR-TB unit
(Table 2). Where appropriate, the score incorporated the date of
implementation (earlier was scored higher than later) and
consistency (greater consistency scored higher than partial or
lower consistency). A total score for each domain was calculated
and converted where necessary, so that each domain was equally
weighted. The sum of the domain scores provided an overall HSP
score for each site with the maximum possible score for any one
site being 160. Annually, over the four year study period a HSP
score per site was calculated. At the end of the study an average
score for each indicator, health system factor and domain was
calculated for each site (Table 3). Similar scoring methodologies
have been used to measure TB and HIV integration at primary
level clinics in South Africa. [15,16].
MDR-TB Treatment and Health Systems Performance
PLOS ONE | www.plosone.org 2 April 2014 | Volume 9 | Issue 4 | e94016
Treatment outcomes (TOs) of patients were determined at the
end of treatment, according to definitions developed by the WHO
(Table 4), [17,18] based on patient data indicating successful
treatment (patient was cured or completed treatment) or
unsuccessful treatment (failure to respond to treatment, default
or death). The overall percentage of these outcomes was calculated
for each of the four sites.
Analysis
Data analyses were conducted using SAS version 9.2 (SAS
Institute Inc., Cary, NC, USA). Differences in outcomes across
sites were compared using binomial regression. Statistical signif-
icance was set at alpha= 0.05. Pearson Product Moment
Correlation coefficients were used to quantify the direction and
magnitude of association between HSP scores and successful TO
by domain.
Qualitative data was explored and analysed in light of the
introduction of a new programme. Using systematic text
condensation (STC) the field notes were read and possible themes
identified. [19] Through decontextualisation and a process of
reflection on commonalities and differences, themes were classified
as codes. Condensation provided meaning to the codes which were
finally synthesised into our conceptual domains.
Results
Treatment Outcomes and HSP Scores
TOs of the 736 patients treated at the 4 decentralised sites are
tabulated in Table 5. Across the four sites, 76% of all patients were
co-infected with HIV. Overall, 58% of patients at the decen-
tralised sites had successful TOs (cured and/or completed).
However, there were differences in treatment outcomes across
the sites. Successful TOs varied from a high of 72% at Site 1 to a
low of 51.7% at Site 4 (p,0.01) and Site 3 and Site 4 had
significantly higher default and death rates respectively (p,0.01).
A detailed comparison of patient characteristics and TOs has been
reported. [12].
Table 1. Framework to monitor health system factors at 4 decentralised MDR-TB sites.
Sub-domains Indicators measuring local site health system factors
Health system factors
Domain: Context
District level: Leadership and ownership MDR-TB perceived as a district problem and not as an MDR-TB unit problem.
District prioritises spending on MDR-TB programme.
District level support: Managerial, administrative,
technical
Staff at PHC sites adequately trained to manage down-referred MDR-TB patients.
Regular visits by district TB co-ordinator.
Facility level support Staff at MDR-TB unit feel supported by facility managers.
Domain: Integration
Integrated services: MDR-TB and HIV Integrated services
Integrated clinical notes
Integrated services: MDR-TB and PHC Mobile clinics re-organised to ensure tracing of TB/MDR-TB defaulters and injecting MDR-TB patients at home.
Integrated services: MDR-TB and TB Communication system for discussing and solving problems with down-referral.
Domain: Mechanism
Human Resources (HR) Availability of staff
Knowledge
Stability and consistency (including staff rotation)
Managerial support
Support services (SS) Pharmaceutical: Availability of drugs
Laboratory: Culture turnaround time
Transport: Needs satisfaction – Percentage of transport requests met
Equipment: Availability, functionality and utilisation
Domain: Output
Continuity of care Referral system: Treatment initiation delay
Mechanism for following up defaulters
Monitoring and evaluation system in place: MDR-TB register up to date
Quality of care Availability of clinical guidelines
Adherence to guidelines: Audit of clinic notes (clinical skills)
Clinical notes adequate and complete: Audit of clinic notes (clinical skills)
Utilisation of clinical expertise at centralised, specialised hospital: Audit telephone calls to doctors at centralised
hospital
Management of serious adverse events immediate and appropriate
doi:10.1371/journal.pone.0094016.t001
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Overall HSP scores varied across the sites with Site 1 having the
highest HSP score (132 out of a possible 160) and Site 4 the lowest
score (59 out of a possible 160) (Figure 1). Site 1 scored highest
score in all domains, achieving the maximum score of 40 in the
domain ‘integration’ compared to Site 2 (score = 24), Site 3
(score = 19), and Site 4 (score = 15). In contrast, Site 4 scored the
lowest in three of the four domains with ‘context’ being the sole
exception.
Analysis by Domains
Context domain scores varied from a high of 29 at Site 1 to a
low of 4 at Site 3 (Figure 1). As a consequence of regular on-site
support visits by the district TB coordinator staff and facility
manager support, staff at Site 1 felt supported by the district and
local hospital, in contrast to staff at the other sites (Table 3:
Context domain: District and facility level support).
‘Whenever we have a problem we phone the district TB co-ordinator.
She is strict with us, but is also helpful.’
(Interview: Site 1: Nurse-in-charge of MDR-TB outpatients
clinic)
‘The district TB co-ordinator came to the opening of this MDR-TB
unit……But since then has never been near. Him and the hospital
managers…….they don’t even know where the unit is.’
‘The hospital managers help with sorting out problems? Never, not one!’
(Interview: Site 3: Nurse-in-charge of MDR-TB outpatients
clinic)
Integration domain scores varied from a high of 32 at Site 1 to a
low of 12 at Site 4 (Figure 1). The two observations below are
examples of the effect of the context domain on integration
(Table 3: Integration domain: Integrated MDR-TB and PHC).
Additional mobile clinics for the MDR-TB programme were identified
by the district in the first year of the programme (2008). The district
mobile services were re-organised so that each mobile provided services
for all TB, HIV and MDR-TB patients in a smaller geographical
area than that in which mobiles had previously operated attending to
TB and HIV patients.
(Field notes Site 1: Repeated observations (ML) 2009–2012)
‘I still don’t have a mobile vehicle for MDR-TB. The district just
ignores me and the hospital managers aren’t concerned.’
(Interview with the nurse-in-charge of MDR-TB unit at Site
3, 12 November 2011. Two mobile vehicles were made
available in January 2012, almost 4 years after the start of
the MDR-TB programme.)
From the mechanism domain a number of human resource
issues affecting the functioning of sites 2–4 emerged. The stability
of the health services was affected by the common hospital practice
of the rotation of front-line health workers through the different
clinical disciplines – a regular practice at sites 2 and 3. At these
sites key clinical staff were rotated every three months through the
different clinical disciplines, including the MDR-TB unit, leading
to low scores for knowledge about MDR-TB, and poor stability
and consistency in the services (Table 3). At Site 1, as two staff
members were on extended sick leave, the site had a low score for
availability of staff. However, this was offset by other HR factors -
the stability and knowledge of remaining staff together with
support for these staff.
Key implementation posts were filled by the same staff
members from 2008–2012. The nurse-in-charge of the MDR-TB
outpatients knows all the patients and as soon as they miss a monthly
appointment are phoned and encouraged to come back.
(Field notes Site 1: Repeated observations (ML) 2009–2012)
Table 2. Examples of Indicators with measurement and scoring systems.
Criteria for measurement/Indicators Evidence Scoring system
Health system factors: District level: Leadership and ownership




MDR-TB reported and discussed in quarterly district TB meetings district TB meetings Consistency
Integrated services: MDR-TB+HIV
% TB and HIV co-infected patients receive MDR-TB/HIV consultation
and management at one desk
Observation Yes or no
Date this started
Consistency
% co-infected patients who do not queue at pharmacy Observation Yes or no
Date this started
Consistency
% clinical notes of co-infected patients which on discharge detail referral for ART Audit of clinic notes Yes or no
Date this started
Consistency
Integrated MDR-TB and PHC services
% mobile clinics re-organised to ensure tracing of TB/MDR-TB defaulters and
injecting MDR-TB patients at home
Transport audit No. of vehicles Date this started
Vehicle logs Consistency
Continuity of care
Mechanism for following up defaulters: % patients who miss visits who are
followed up and his is documented in folder
Audit of clinic notes Yes or no
doi:10.1371/journal.pone.0094016.t002
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The nurse-in-charge of the MDR-TB outpatients was
rotated every three months. The appointment systems were not
functional, as she didn’t know the patients and was unaware if they
missed appointments. Consequently, this site had a significantly higher
default rate than the other sites (p,0.01) (Table 3).
(Field notes Site 3: Repeated observations (ML) 2009–2012:
Interpretation of TOs: August)
Consistency of services was undermined by a second common
human resource practice - the appointment of managers in ‘acting’
positions. Site 4 scored a 0 for managerial support (Table 3).
I took up a problem that had emerged with the ‘acting’ head
of Site 4 MDR-TB unit.
Table 3. Scores allocated for health system factors at the 4 decentralised sites.












District level: Leadership and MDR-TB perceived as a district problem and not
as an MDR-TB unit problem
8 8 0 0 3
ownership District prioritises spending on MDR-TB programme 5 3 1 1 1
District level support:
Managerial, technical
Staff at PHC sites adequately trained to manage
MDR-TB down-referred patients
8 6 3 2 3
+ administrative Regular visits by district TB co-ordinator 5 2 0 0 1
Facility level support MDR-TB unit staff feel supported by facility managers 3 2 0 0 0
Total context score 29 21 4 3 8
Weighted context score 40 29 6 4 11
Domain: Integration
Integrated MDR-TB and HIV Integrated services 13 13 9 7 6
Integrated clinical notes 8 8 5 5 3
Integrated MDR-TB and PHC Mobile clinics re-organised to ensure tracing of
TB/MDR-TB
defaulters and injecting MDR-TB patients at home.
8 8 5 3 0
Integrated MDR-TB and TB Communication system for discussing and
solving problems with down-referral
3 3 2 0 3
Total integration score 32 32 21 15 12
Weighted integration score 40 40 24 19 15
Domain: Mechanism
Human resources Availability of staff 10 2 7 7 5
Knowledge 3 3 3 1 3
Stability and consistency 4 4 2 2 2
Managerial support 4 4 3 0 0
Support services Pharmaceutical: Availability of drugs 4 3 0 3 2
Laboratory: Culture turnaround time 8 8 8 5 1
Transport: Needs satisfaction - % of transport requests met 1 1 0 1 0
Equipment: Availability and utilisation 5 5 3 1 1
Total mechanism score 39 30 26 20 14
Weighted mechanism score 40 31 27 20 14
Domain: Output
Continuity of care Referral system: Treatment initiation delay 9 4 4 4 2
Mechanism for following up defaulters 3 3 3 2 3
M+E system in place: MDR register up to date 3 3 2 2 2
Quality of care Availability of clinical guidelines 5 5 1 3 2
Adherence to guidelines: Audit of clinic notes 3 1 0 0 0
Clinical notes adequate and complete: Audit of clinic notes 3 3 2 2 1
Utilisation of clinical expertise at KGV:
Audit telephone calls to KGV doctors
3 3 1 2 1
Management of serious adverse events immediate and appropriate 6 6 6 6 6
Total output score 35 28 19 21 17
Weighted output score 40 32 22 24 19
doi:10.1371/journal.pone.0094016.t003
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‘Well, I’m only acting. I can’t do anything.’
(Field notes and interview September 2010: Acting head of
the Site 4 MDR-TB unit)
From the output domain quality of care varied across the four
sites and inadequate clinical skills together, and poor adherence to
clinical guidelines contributed to fewer successful TOs at Sites 2, 3
and 4 (Table 3).
‘I am only working in the MDR-TB unit for 3 months. I haven’t seen
any guidelines. I follow what was done before. Dr. X who worked here
before is around. I haven’t spoken to him. He is busy, and so am I.’
(Interview with clinician at Site 2, April 2010)
Doctors at this site are rotated through the MDR-TB unit every three
months and not all of them familiarise themselves with the guidelines. A
new doctor stopped the injectable phase in three patients after four
months, two months too early. Two of the patients subsequently failed
treatment.
(Observational data at Site 2: Repeated observations (ML)
2009–2012: Interpretation of TOs August 2012)
Association between TOs and HSP
We found a correlation between successful TOs and total HSP
score (r = 0.99, p,0.01) (Table 6, Figure 2). Quantitative data
analysis suggested that the domain ‘integration’, had the strongest
association with successful treatment outcomes (r = 0.99, p,0.01)
(Table 6). However, qualitative data indicated that issues within
the domain ‘context’ influenced both programme implementation
and the ‘integration’ domain.
Discussion
Our exploratory study suggests there is an association between
treatment outcomes (TOs) and Health System Performance (HSP).
We found this association to be significant (r = 0.99, p,0.01), with
Site 1 having the highest number of successful TOs and the highest
total HSP score. Conversely, Site 4 had the lowest number of
successful TOs and the lowest HSP score. In addition, our study
suggests that the ‘context’ and ‘integration’ domains had the
strongest association with successful TOs.
District level ownership and leadership enabled re-organisation
and realignment of services at Site 1, the ‘integration’ domain.
Different health system components, such as pharmaceutical and
transport services, were incorporated into the new programme
and, the inclusion of local key personnel with grounded clinical
Table 4. Treatment outcome definitions*.
Treatment outcome Definitions
Cure Cure was defined as completion of treatment and $5 consecutive
negative culture results in the final 12 months of treatment.
Treatment completion Treatment completion referred to completion of therapy but without
bacteriologic documentation of cure.
Treatment success Treatment success has been defined as the percentage of patients in whom the treatment outcome
was either cured or completed. That is, ‘‘% successful = no. of patients
cured+no. of patients completed treatment/Total no. initiated treatment6100’’.
Treatment failure Treatment failure was defined as having more than one positive culture in the final 12 months of therapy,
or if any one of the final three cultures was positive, or if more than one drug in the treatment regimen was
replaced,
or if treatment was terminated due to adverse events or no clinical improvement.
Default Default was defined as an interruption in treatment for $2 consecutive months for any reason.
Death Death was defined as all-cause mortality during MDR-TB treatment.
Unsuccessful treatment Unsuccessful treatment outcome has been defined as the percentage of patients in whom the treatment
outcome was died, defaulted, or failed treatment.
Transferred out Transferred out: A patient with MDR-TB who was transferred to another reporting and
recording unit a year after study-enrolment whose treatment outcome is unknown.
*Treatment outcome definitions used are WHO definitions for the management of MDR-TB. [17,18]
doi:10.1371/journal.pone.0094016.t004
Table 5. Treatment outcomes of patients with MDR-TB treated at 4 decentralised sites in KwaZulu-Natal, South Africa*.
Treatment Outcomes Site 1 Site 2 Site 3 Site 4 p-value All decentralized hospitals
n=125 n=148 n=202 n=261 n=736
Treatment success 90 (72.0) 89 (60.1) 113 (55.9) 135 (51.7) ,0.01 427 (58.0)
Died 17 (13.6) 22 (14.9) 25 (12.4) 69 (26.4) ,0.01 133 (18.1)
Failed 7 (5.6) 11 (7.4) 12 (5.9) 19 (7.3) 0.87 49 (6.7)
Defaulted 9 (7.2) 20 (13.5) 50 (24.8) 28 (10.7) ,0.01 107 (14.5)
Data are number (%), unless otherwise indicated.
*Treatment outcome definitions used are WHO definitions, as defined in Table 4.
doi:10.1371/journal.pone.0094016.t005
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experience and knowledge of the local situation resulted in the
development of a model of care which built on available strengths
and was appropriate for local needs. [20–22] For front line health
workers and facility managers at Site 1, district-level ownership
translated into regular on-site support visits by the district TB co-
ordinator. These visits provided encouragement and supervision,
and aided in the resolution of site-level problems, thereby enabling
health care workers to deal with emerging difficulties instead of
becoming ‘mired in inertia’. [23] In addition, the visits led to
increased accountability and a commitment to patient care
resulting in improved adherence and a higher number of
successful TOs.
In contrast to Site 1, district and facility managers at Sites 2, 3
and 4 in failing to own the MDR-TB problem, underestimated the
realignments and changes necessary for the health system. This led
to partial implementation of the programme, limited managerial
and support services support, delays in the re-organisation of the
human resources and re-allocation of vehicles and poor integration
of the MDR-TB programme into existing PHC services.
Furthermore, as staff at Sites 2, 3 and 4 were not visited regularly
they felt unsupported and unvalued, were unmotivated, and lacked
commitment to their work and their patients, resulting in fewer
successful TOs. Other authors support this interpretation; they
have shown that ‘context’ has a high impact on the capacity of
health services to co-ordinate and support effective service
delivery. [24–26] In a study evaluating the HIV programme in
Russia, Tkatchenko-Schmidt et al [27] described the impact of
leadership, ownership and support on staff motivation and
performance. A systematic review which examined the relation-
ship between nursing leadership and patient outcomes found a
significant association between positive leadership and increased
patient satisfaction and reduced adverse events. [28] Other studies
have documented the effect of political and managerial leadership
on health system functioning and the increased likelihood of
unsuccessful TOs when health systems are dysfunctional.[26,29–
32].
Much has been written about the need for and importance of
vertical health programmes strengthening health systems. [33,34]
In our study, district level leadership at Site 1 integrated the new
decentralised MDR-TB vertical programme into the existing
district health services. The re-alignment and re-organisation of
the services enabled the district health system to benefit from and
be strengthened by the introduction of a new programme. In
contrast, at the other sites, the new programme with its additional
resources were not integrated into horizontal service delivery, and
the existing services neither strengthened nor capacitated. In
addition, the integration of the MDR-TB and HIV programmes at
Site 1 would have contributed to successful TOs, as the role of
ART in the successful treatment of co-infected patients is well
documented. [35,36].
Inadequate clinical skills together with delayed implementation
of changes to clinical guidelines contributed to Sites 2, 3 and 4
scoring poorly in the quality of care component of the domain
‘output’ and achieving fewer successful TOs. In a recent article on
new TB diagnostics, the difficulties in implementing new
guidelines or changes to guidelines are described. [37] In this
Figure 1. Breakdown of total health systems performance score by domain at 4 decentralised MDR-TB sites. The four sites are plotted
on the X-axis and the health system performance score on the Y-axis. Health system performance is the sum (cumulative score) of the four different
domains (output, mechanism, integration and context), which are shaded differently. Site 1 had the highest score of 132 which comprised scores of
32 for the output domain, 31 for the mechanism domain, 40 for the integration domain and 29 for the context domain.
doi:10.1371/journal.pone.0094016.g001
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article the authors emphasise that even small changes in guidelines
or algorithms are a major undertaking in a national TB
programme. Given recent advances in TB diagnostics and therapy
and possible changes to algorithms and regimens, national TB
programmes need to be cognisant of the complexity of change. Up
to date guidelines must be available at facilities and in our study
guidelines were consistently available at Site 1 only (Table 3).
Other studies have documented the negative impact of unavailable
guidelines and protocols on quality of care. [38,39].
To ensure that the most up-to-date guidelines and regimens are
implemented, regular on-going training, support and supervision
at the decentralised sites is necessary. Given that the sites are
scattered throughout a large province, different models for
providing ongoing training, such as electronic or in-service, need
Figure 2. Association between successful treatment outcomes and total health systems performance score at 4 decentralised MDR-
TB sites. This figure shows the association between successful treatment outcomes and total health systems performance score. The percentage of
successful treatment outcomes is plotted on the Y-axis and the health performance score on the X-axis. From the graph it can be seen that Site 1 had
the highest treatment success and highest total health system performance score. Sites 2, 3 and 4 can be seen to have lower health system
performance scores and lower rates of treatment success. This graph shows there was an association between successful treatment outcomes and
total Health System Performance score (r = 0.99) and that this association was significant (p,0.01).
doi:10.1371/journal.pone.0094016.g002
Table 6. Correlation between health system performance and successful treatment outcomes for each domain for MDR-TB
patients treated at 4 decentralised sites.






Human resources (HR) 0.42 0.58
Support services (SS) 0.96 0.04
doi:10.1371/journal.pone.0094016.t006
MDR-TB Treatment and Health Systems Performance
PLOS ONE | www.plosone.org 8 April 2014 | Volume 9 | Issue 4 | e94016
to be explored. [40,41] In addition, regular, careful support and
supervision improves quality of services significantly. [42] If staff
feel supported and confident, they are less likely to seek alternative
employment. Moreover, to ensure optimal implementation,
district and facility managers need support, supervision and
monitoring to ensure they take ownership of a new programme,
take responsibility for service re-organisation and re-alignment and
provide support.
Besides the lack of support for front-line staff at Sites 2, 3 and 4,
two routine HR practices contributed to poor HSP. This regular
rotation of clinical staff contributed to the loss of valuable skills and
experience and instability and a lack of continuity in MDR-TB
management. The practice of rotation has to be reconsidered for
key clinical positions such as the doctor responsible for MDR-TB
services and the nurse-in-charge of the outpatient clinic. If rotation
is necessary, a longer rotational cycle would reduce the rapidity
with which skills are lost.
Secondly, in resource-constrained settings, a strategy used to
reduce personnel costs is to appoint staff as ‘acting’ managers. Site
4 had an acting facility manager for much of the study period,
which, together with a number of other factors contributed to the
poor HSP at this site. This stalling tactic for key delivery positions
is counter-productive resulting in unmotivated and unproductive
staff, poor service implementation and poor patient care.
The importance of the head of the outpatient clinic in health
services for chronic and long-term conditions is seldom recognised.
In decentralised MDR-TB services, this person is the interface
between MDR-TB and PHC services and the community as well
as being the gateway to tertiary care. First, she has to ensure that
the service is patient-focussed, the patient is supported and
constant education is provided to promote adherence. Second, she
is responsible for co-ordination of two different programmes (TB
and HIV), and for the organisation of different and diverse support
service components to ensure health service performance is
optimal. And third, she acts as a liaison between the different
levels of care so that the patient always receives appropriate
treatment.
Limitations
This study was an evaluation of an intervention implemented in
the public sector, providing evidence under routine conditions
which supports wider applicability of results. However, it was
subject to challenges experienced in this sector. Our data used for
the evaluation was the data routinely collected by health workers,
which at times, was incomplete and inaccurate. Although we
collected individual patient data, the routinely collected health
system data were not available at an individual level. And,
therefore, we were unable to determine the impact of HSP on
individual patient TOs. By focusing on health system performance
other factors, such as differences in baseline characteristics, which
may have influenced TOs were not included in the analysis.
Furthermore, the small sample size (4 sites) lessened the power of
tests, reduced precision, increased the effect of variability and
precluded the use of more sophisticated methods to determine the
association of different domains to one another.
Conclusions
This study is a first step toward predicting which health system
factors affect treatment outcomes (TOs). In spite of the above
limitations, we have shown that there is a trend between HSP and
TO and a larger case control or comparative study is warranted.
To conclude, we suggest that decentralised MDR-TB manage-
ment can improve treatment outcomes if district leadership is
effective, management takes ownership of the problem and
provides support by re-organising and re-aligning health service
components, allocating sufficient financial resources, and provid-
ing regular visits and assistance in resolving emerging problems.
Moreover, a vertical programme can strengthen district level
health systems if it is integrated into existing services.
As MDR-TB prevalence increases, health services expand, and
different models of care are introduced, we recommend regular
monitoring and support of district and facility managers and
individual health workers to encourage service integration,
guideline adherence and optimize TOs.
In addition, we have identified HR practices that are
detrimental to HSP: rotation of staff in key clinical positions and
the appointment of managerial staff in an ‘acting’ capacity. We





We thank facility level managers, doctors, nurses and data capturers at the
study sites for their assistance.
Author Contributions
Conceived and designed the experiments: ML NP KW JR JB JN IM AV.
Performed the experiments: ML KW JN AV. Analyzed the data: ML JR
NP KW JB JN AV. Contributed reagents/materials/analysis tools: ML NP
KW JR JB JN IM AV. Wrote the paper: ML NP KW JR JB JN IM AV.
References
1. Wallengren K, Scano F, Margot B, Nunn P, Buthelezi S, et al. (2011) Drug-
Resistant Tuberculosis, KwaZulu-Natal, South Africa, 2001–2007. EID 17:
1913–1916.
2. Zager E, McNerney R (2008) Multidrug-resistant tuberculosis. BMC Infectious
Diseases 8: doi:10.1186/1471-2334-1188-1110.
3. Kawonga M, Blaauw D, Fonn S (2012) Aligning vertical interventions to health
systems: a case study of the HIV monitoring and evaluation system in South
Africa. Health Research Policy and Systems 10.
4. Atun R, de Jongh T, Secci F, Ohiri K, Adeyi O (2010) A systematic review of the
evidence on integration of targeted health interventions into health systems.
Health Policy and Planning 25: 1–14.
5. Rao K, Ramani S, Hazarika I, George S (2013) When do vertical programmes
strengthen health systems? A comparative assessment of disease-specific
interventions in India. Health Policy and Planning 1–11.
6. Nathanson E, Lambregts-van Weezenbeek C, Rich M, Gupta R, Bayona J, et al.
(2006) Multidrug-resistant tuberculosis management in resource-limited settings.
Emerg Infect Dis 12: 1389–1397.
7. Toczek A, Cox H, du Cros P, Cooke G, Ford N (2013) Strategies for reducing
treatment default in drug-resistant tuberculosis: systematic review and meta-
analysis. Int J Tuberc Lung Dis 17: 299–307.
8. Brust J, Gandhi N, Carrara H, Osburn G, Padayatchi N (2010) High treatment
failure and default rates for patients with multidrug-resistant tuberculosis in
KwaZulu-Natal, South Africa, 2000–2003. Int J Tuberc Lung Dis 14: 413–419.
9. Farley J, Ram M, Pan W, Waldman S, Cassell G, et al. (2011) Outcomes of
Multi-Drug Resistant Tuberculosis (MDR-TB) among a Cohort of South
African Patients with High HIV Prevalence. PLoS ONE 6: e20436.
doi:20410.21371/journal.pone.0020436.
10. Jain A, Dixit P (2008) Multidrug-resistant to extensively drug resistant
tuberculosis: what is next? J Biosci 33: 605–616.
11. Loveday M, Wallengren K, Voce A, Margot B, Reddy T, et al. (2012)
Comparing early treatment outcomes of MDR-TB in decentralised and
centralised settings in KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis
16: 209–215.
12. Loveday M, Padayatchi N, Roberts J, Voce A, Brust J, et al. Decentralised vs.
centralised care for MDR-TB patients: A comparison of final treatment
MDR-TB Treatment and Health Systems Performance
PLOS ONE | www.plosone.org 9 April 2014 | Volume 9 | Issue 4 | e94016
outcomes in KwaZulu-Natal, South Africa; Kuala Lumpur, Malaysia. [Abstract
#PC-487-15]. Int J Tuberc Lung Dis 2012: 16 (Suppl 1): S136–S137.
13. Coker R, Balen J, Mounier-Jack S, Shigayeva A, Lazarus J, et al. (2010) A
conceptual and analytical approach to comparative analysis of country case
studies: HIV and TB control programmes and health systems integration.
Health Policy and Planning 25: i21–i31.
14. Loveday M, Zweigenthal V (2011) TB and HIV integration: obstacles and
possible solutions to implementation in South Africa. Trop Med Int Health 16:
431–438.
15. Loveday M, Scott V, McCoughlin J, Amien F, Zweigenthal V (2011) Assessing
care for patients with TB/HIV/STIs in a rural district in KwaZulu-Natal SAMJ
101: 887–890.
16. Scott V, Chopra M, Azevedo V, Caldwell J, Naidoo P, et al. (2010) Scaling up
integration: Development and results of a participatory assessment of HIV/TB
services, South Africa Health Research Policy and Systems 8: 1–11.
17. Laserson K, Thorpe L, Leimane V, Weyer K, Mitnick C, et al. (2005) Speaking
the same language: treatment outcome definitions for multidrug-resistant
tuberculosis. Int J Tuberc Lung Dis 9: 640–645.
18. World Health Organisation (2008) Guidelines for the programmatic manage-
ment of drug-resistant tuberculosis. Emergency Update 2008. WHO/HTM/
TB/2008.402. Geneva: World Health Organisation.
19. Malterud K (2012) Systematic text condensation: A strategy for qualitative
analysis. Scandinavian Journal of Public Health 40: 795.
20. May C, Finch T, Mair F, Ballini L, Dowrick C, et al. (2007) Understanding the
implementation of complex interventions in health care: the normalization
process model. BMC Health Serv Res 7: 148.
21. Georgeu D, Colvin C, Lewin S, Fairall L, Bachmann M, et al. (2012)
Implementing nurse-initiated and managed antiretroviral treatment (NIMART)
in South Africa: a qualitative process evaluation of the STRETCH trial.
Implementation Science 7: doi:10.1186/1748-5908-1187-1166.
22. Schneider H, Coetzee D, Van Rensburg D, Gilson L (2010) Differences in
antiretroviral scale up in three South African provinces: the role of
implementation management. BMC Health Services Research 10: S4. Available:
http://www.biomedcentral.com/1472-6963/1410/S1471/S1474.
23. Van Rensburg D (2006) The Free State’s approach to implementing the
‘‘Comprehensive Plan,’’ notes by a participant outsider. Acta Academica Suppl
1: 44–93.
24. Atun R, Bataringaya J (2011) Building a Durable Response to HIV/AIDS:
Implications for Health Systems. J Acquir Immune Defic Syndr 57: S91–S95.
25. van Olmen J, Criel B, Bhojani U, Marchal B, van Belle S, et al. (2012) The
Health System Dynamics Framework: The introduction of an analytical model
for health system analysis and its application to two case-studies. Health, Culture
and Society 2: DOI 10.5195/hcs.2012.5171.
26. Atun R (2012) Health systems, systems thinking and innovation. Health Policy
and Planning 27: iv4–iv8 doi:10.1093/heapol/czs1088.
27. Tkatchenko-Schmidt E, Atun R, Wall M, Tobi P, Schmidt J, et al. (2010) Why
do health systems matter? Exploring links between health systems and HIV
response: a case study from Russia. Health Policy and Planning 25: 283–291.
28. Wong C, Cummings G (2007) The relationship between nursing leadership and
patient outcomes: a systematic review. Journal of Nursing Management 15: 508–
521.
29. Atun R, Coker R, editors (2008) Health systems and communicable disease
control: emerging evidence and lessons from central and eastern Europe.
Maidenhead Open University Press, McGraw Hill Education.
30. Willenbring M (2005) Integrating care for patients with infectious, psychiatric,
and substance use disorders: concepts and approaches. AIDS 19: S227–237.
31. Tkatchenko-Schmidt E, Renton A, Gevorgyan R, Davydenko L, Atun R (2008)
Prevention of HIV/AIDS among injecting drug users in Russia: opportunities
and barriers to scaling-up of harm reduction programmes. Health Policy and
Planning 85: 162–171.
32. Pablos-Mandez A, Gowda D, Frieden T (2002) Controlling multidrug-resistant
tuberculosis and access to expensive drugs: a rational framework. Bull World
Health Organ 80: 489–500.
33. Atun R, Lazarus J, Van Damme W, Coker R (2010) Interactions between
critical health system functions and HIV/AIDS, tuberculosis and malaria
programmes Health Policy and Planning 25: 1–3.
34. World Health Organisation (2007) Everybody business: strengthening health
systems to improve health outcomes: WHO’s framework for action. Geneva,
Switzerland. ISBN 978 92 4 159607 7: World Health Organization.
35. Gandhi N, Shah S, Andrews J, Vella V, Moll A, et al. (2010) HIV Co-infection
in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High
Early Mortality. Amer J Resp Crit Care Med 181: 80–86.
36. Isaakidis P, Cox H, Varghese B, Montaldo C, Da Silva E, et al. (2011)
Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a
Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India. PLoS
ONE 6: e28066. doi:28010.21371/journal.pone.0028066.
37. Pai M, Palamountain K (2012) New tuberculosis technologies: challenges for
retooling and scale-up [State of the art series. New tools. Number 4 in the series].
Int J Tuberc Lung Dis 16: 1281–1290.
38. Edward A, Kumar B, Kakar F, Salehi A, Burnham G, et al. (2011 ) Configuring
Balanced Scorecards for Measuring Health System Performance: Evidence from
5 Years’ Evaluation in Afghanistan. PLoS Med 8: e1001066. doi:
1001010.1001371/journal.pmed.1001066.
39. Mutale W, Godfrey-Fausset P, Mwanamwenge M, Kasese N, Chintu N, et al.
(2013) Measuring Health System Strengthening: Application of the Balanced
Scorecard Approach to Rank the Baseline Performance of Three Rural Districts
in Zambia. PLoS ONE 8: e58650. doi:58610.51371/journal.pone.0058650.
40. Fairall L, Zwarenstein M, Bateman E, Bachmann M, Lombard C, et al. (2005)
Effect of educational outreach to nurses on tuberculosis case detection and
primary care of respiratory illness: pragmatic cluster randomised controlled trial.
BMJ 331: 750–754.
41. Zwarenstein M, Fairall L, Lombard C, Mayers P, Bheekie A, et al. (2011)
Outreach education for integration of HIV/AIDS care, antiretroviral treatment,
and tuberculosis care in primary care clinics in South Africa: PALSA PLUS
pragmatic cluster randomised trial. BMJ 342: d2022 doi:2010.1136/bmj.d2022.
42. Reynolds H, Toroitich-Ruto C, Nasution M, Beaston-Blaakman A, Janowitz B
(2008) Effectiveness of training supervisors to improve reproductive health
quality of care: a cluster-randomized trial in Kenya. Health Policy and Planning
23.
MDR-TB Treatment and Health Systems Performance
PLOS ONE | www.plosone.org 10 April 2014 | Volume 9 | Issue 4 | e94016
